Rationale for fixed dosing of pertuzumab in cancer patients based on population pharmacokinetic analysis. [electronic resource]
Producer: 20070213Description: 1275-84 p. digitalISSN:- 0724-8741
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Body Surface Area
- Body Weight
- Breast Neoplasms -- drug therapy
- Drug Administration Schedule
- Female
- Humans
- Infusions, Intravenous
- Middle Aged
- Models, Biological
- Ovarian Neoplasms -- drug therapy
- Randomized Controlled Trials as Topic
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.